Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir

OBJECTIVES: Co-treatment of HIV and TB in young children is complicated by limited treatment options and complex drug–drug interactions. Rifabutin is an alternative to rifampicin for adults receiving a ritonavir-boosted PI. We aimed to evaluate the short-term safety and pharmacokinetics of rifabutin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Antimicrob Chemother
Autori principali: Moultrie, Harry, McIlleron, Helen, Sawry, Shobna, Kellermann, Tracy, Wiesner, Lubbe, Kindra, Gurpreet, Gous, Hermien, Van Rie, Annelies
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2015
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4291235/
https://ncbi.nlm.nih.gov/pubmed/25281400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dku382
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi